SOURCE: Gamma Pharmaceuticals, Inc.

April 13, 2010 08:00 ET

Gamma Pharmaceuticals, Inc.: Evander Holyfield Stops Francois Botha in the 8th Round to Begin Quest to Become the Only 5-Time World Heavyweight Champion at Age 47

LAS VEGAS, NV--(Marketwire - April 13, 2010) -  Gamma Pharmaceuticals, Inc. (PINKSHEETS: GMPM) ("Gamma" or "the Company") co-founder and shareholder of Gamma-Holyfield Choice LLC and four-time boxing world heavyweight champion, Evander Holyfield, defeated (by KO) Francois Botha in the eighth round to earn the WBF crown on Saturday night at The Thomas and Mack Center in Las Vegas. http://boxing.fanhouse.com/2010/04/11/evander-holyfield-stops-francois-botha/

Peter Cunningham, Gamma's CEO, stated, "It was a great fight, and quite awe-inspiring to see Evander, at age 47, display eight rounds of truly extraordinary physical stamina and strength. This almost superhuman achievement showed why he is generally considered to be one of the best heavyweight fighters of all time, and confirmed to Gamma that we could have found no better partner for our exclusive line of high performance vitamins and supplements." Cunningham noted, "Most men Evander's age pursue light jogging or non-contact sports only with a doctor's okay, and here was Evander, going eight rounds and finishing the contest with a sledgehammer left, a physical marvel with the physique, power, stamina and skills of a man half his age. It may sound corny, but Evander may have found a fountain of youth. Our Holyfield Choiceline of vitamin and nutritional products for athletes in training and professional athletes are designed as the ideal complement to Evander's health and wellness regimen. Evander has collaborated closely with Gamma in developing this outstanding product line." 

On March 1, 2010, Gamma announced the formation of a Joint Venture Company with Evander Holyfield. Mr. Holyfield is the only 4-time Boxing World Heavyweight Champion and in unaided focus groups is identified as one of the world's most recognized athletes. The joint venture, branded Holyfield Choice™, is formulating and marketing an innovative line of vitamins and nutritional products utilizing Mr. Holyfield's expertise in nutrition and physical training and Gamma's formulation and marketing knowhow. Holyfield Choice is closely integrated with Gamma's existing corporate infrastructure and distribution channels, and currently has four product lines and seven SKUs, with plans for expansion. Under the terms of the venture, Gamma will consolidate the joint venture's performance into Gamma's financials. 

About Gamma Pharmaceuticals, Inc.

Gamma Pharmaceuticals, Inc. (www.gammapharma.com) is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally. Gamma's core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in the United States and Greater China. Branded nutritional supplements are sold under the trademarks Brilliant Choice™ children's nutritional supplements featuring the call to action, "Mom you've made a brilliant choice for you children's nutrition;" SAVVY™ adult nutritional supplements featuring the call to action, "Be SAVVY Stay Healthy;" and, Jugular Energy Products™ and high performance supplements featuring the call to action, "Go for the Jugular™." Gamma's customer focus is on selling products in the Lifestyle of Health & Sustainability ("LOHAS") marketplace and in the Energy Supplement Market. A series of innovative marketing programs supports Gamma's product sales and retail partners.

At present Gamma's products are manufactured in North America, and distributed in the United States and China. Gamma's products utilize proprietary "Gel Delivery Technology®," designed to create innovative gel product forms; that give consumers a more pleasant experience. Gel Delivery Technology® characteristics include rapid absorption, convenience and taste great. Market categories Gamma targets are growing as rapidly as 60% per year. Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress Reduction, Cognition, Well being, Menopause Symptoms and Personal Care Products. Gamma also develops and manufactures house brands for major retailers. At this time, Gamma has a total of 36 SKUs and holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company's stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contact Information